A Synthetic Matrix Metalloproteinase Inhibitor Decreases Tumor Burden and Prolongs Survival of Mice Bearing Human Ovarian Carcinoma Xenograft

Cancer Research

Volumn 53, Issue 9, 1993, Pages 2087-2091

  Davies, Bernard ^a   Brown, Peter D ^b   East, Nick ^a   Crimmin, Michael J ^b   Balkwill, Frances R ^a  

^a IMPERIAL CANCER RESEARCH FUND   (United Kingdom)

^b British Biotechnology   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

COLLAGEN TYPE 4; COLLAGENASE; METALLOPROTEINASE; METALLOPROTEINASE INHIBITOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASCITES; CANCER SURVIVAL; MOUSE; NONHUMAN; NUDE MOUSE; OVARY CARCINOMA; PRIORITY JOURNAL; SOLID TUMOR; TUMOR GROWTH; TUMOR VOLUME; TUMOR XENOGRAFT;

AGED; ANIMAL; CARCINOMA; CELL DIVISION; EXTRACELLULAR MATRIX; FEMALE; HUMAN; IN VITRO; METALLOENDOPEPTIDASES; MICE; MOLECULAR STRUCTURE; NEOPLASM TRANSPLANTATION; OVARIAN NEOPLASMS; PHENYLALANINE; SURVIVAL ANALYSIS; THIOPHENES; TRANSPLANTATION, HETEROLOGOUS; TUMOR CELLS, CULTURED;

EID: 0027251836     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Collier, I. E. Wilhelm, S. M. Eisen, A. Z. Marmer, B. L. Grant, G. A. Seltzer, J. L. Kronberger, A. He, C. Bauer, E. A. and Goldberg, G. I. H-ras oncogene-transformed human bronchial epithelial cells (TBE-1) secrete a single metalloproteinase capable of degrading basement membrane collagen. J. Biol. Chem. 263: 6579-6587, 1988.
2. Ward, R. V. Atkinson, S. J. Slocombe, P. M. Docherty, A. J. P. Reynolds, J. J. and Murphy, G. Tissue inhibitor of metalloproteinase-2 inhibits the activation of 72 kDa progelatinase by fibroblast membranes. Biochim. Biophys. Acta, 1079: 242-246, 1991.
3. Chin, J. R. Murphy, G. and Werb, Z. Stromelysin, a connective tissue-degrading metalloendopeptidase secreted by stimulated rabbit synovial fibroblast in parallel with collagenase. J. Biol. Chem. 260: 12367-12376, 1985.
4. Reponen, P. Sahlberg, C. Huhtala, P. Hurskainen, T. Thesleff, I. and Tryggvason, K. Molecular cloning of murine 72-kDa type IV collagenase and its expression during mouse development. J. Biol. Chem. 267: 7856-7862, 1992.
5. Agren, M. S. Taplin, C. J. Woessner, J. F. Eaglstein, W. H. and Mertz, P. M. Collagenase activity during wound-healing. J. Invest. Dermatol. 98: 621-621, 1992.
6. Okada, Y. Nagase, H. and Harris, E. D. Jr. Matrix metalloproteinase 1, 2, and 3 from rheumatoid synovial cells are sufficient to destroy joints. J. Rheumatol. 14: 41-42, 1987.
7. Alvarez, O. A. Carmichael, D. F. and DeClerck, Y. A. Inhibition of collagenolytic activity and metastasis of tumor cells by a recombinant human tissue inhibitor of metalloproteinases. J. Nad. Cancer Inst. 82: 589-595, 1990.
8. Hendrix, M. J. Wood, W. R. Seftor, E. A. Lotan, D. Nakajima, M. Misiorowski, R. L. Seftor, R. E. Stetler-Stevenson, W. G. Bevaqua, S. J. Liotta, L. A. et al. Retinoic acid inhibition of human melanoma cell invasion through a reconstituted basement membrane and its relation to decreases in the expression of proteolytic enzymes and motility factor receptor. Cancer Res. 50: 4121-4130, 1990.
9. Herlyn, D. Iliopoulos, D. Jensen, P. J. Parniter, A. Baird, J. Hotta, H. Adachi, K. Ross, A. H. Jambrosic, J. Koprowski, H. et al. In vitro properties of human melanoma cells metastatic in nude mice. Cancer Res. 50: 2296-2302, 1990.
10. Moses, M. A. Sudhalter, J. and Langer, R. Identification of an inhibitor of neovascularization from cartilage. Science (Washington DC), 248: 1408-1410, 1990.
11. Ward. B. G. Wallace, K. Shephard, J. H. and Balkwill, F. R. Intraperitoneal xenografts of human epithelial ovarian cancer in nude mice. Cancer Res. 47: 2662-2667, 1987.
12. Brown, P. D. Levy, A. T. Marguiles, I. M. K. Liotta, L. A. and Stetler-Stevenson, W. G. Independent expression and cellular processing of Mr 72, 000 type IV collagenase and interstitial collagenase in human tumorigenic cell lines. Cancer Res. 50: 6184-6191, 1990.
13. Bagley, C. M. Jr. Young, R. C. Canellos, G. P. et al. Treatment of ovarian carcinoma: possibilities for progress. N. Engl. J. Med. 287: 856-862, 1972.
14. Tobias, J. S. and Griffiths, C. T. Management of ovarian carcinoma: current concepts and future prospects. N. Engl. J. Med. 294: 818-823, 1976.
15. Folkman, J. Tumour angiogenesis. Adv. Cancer Res. 43: 175-203, 1985.
16. Dvorak, H. F. Tumors: wounds that do not heal. N. Engl. J. Med. 315: 1650-1659, 1986.
17. Nagy, J. A. Brown, L. F. Senger, D. R. Lanir, N. Van Der Water, L. Dvorak, A. M. and Dvorak, H. F. Pathogenesis of tumor stroma generation: a critical role for leaky blood vessels and fibrin deposition. Biochim. Biophys. Acta, 94: 305-326, 1988.
18. Barsky, S. H. Rao, C. N. Grotendorst, G. R. and Liotta, L. A. Increased content of type V collagen in desmoplasia of human breast carcinoma. Am. J. Pathol. 108: 276-283, 1982.
19. Monteagudo, C. Merino, M. J. San-Juan, J. Liotta, L. A. and Stetler-Stevenson, W. G. Immunohistochemical distribution and type IV collagenase in normal, benign and malignant breast tissue. Am. J. Pathol. 136: 585-592, 1991.
20. Poulsom, R. Pignatelli, M. Stetlerstevenson, W. G. Liotta, L. A. Wright, P. A. Jeffery, R. E. Longcroft, J. M. Rogers, L. and Stamp, G. W. H. Stromal expression of 72 kDa type IV collagenase (mmp. 2) and TIMP-2 messenger RNAs in colorectal neoplasia. Am. J. Pathol. 141: 389-396, 1992.
21. Pyke, C. Ralfkiaer, E. Huhtala, P. Hurskainen, T. Dano, K. and Tryggvason, K. Localization of messenger RNA for Mr 72, 000 and 92.000 type IV collagenases in human skin cancers by in situ hybridization. Cancer Res. 52: 1336-1341, 1992.
22. Gray, S. T. Wilkins, R. J. and Yun, K. Interstitial collagenase gene expression in oral squamous cell carcinoma. Am. J. Pathol. 141: 301-306, 1992.
23. Hewitt, R. E. Leach, I. H. Powe, D. G. Clark, I. M. Cawston, T. E. and Turner, D. R. Distribution of collagenase and tissue inhibitor of metalloproteinase (TIMP) in colorectal tumors. Int. J. Cancer, 49: 666-672, 1991.
24. Basset, P. Bellocq, J. P. Wolf, C. Stoll, I. Hutin. P. Limacher, J. M. Podhajcer, O. L. Chenard, M. P. Rio, M. C. and Chambon, P. A novel metalloproteinase gene specifically expressed in stromal cells of breast carcinomas. Nature (Lond.), 348: 699-704, 1990.
25. Malik. S. T. A. Griffin, D. B. Naylor, M. S. Fiers, W. Oliff, A. and Balkwill, F. R. The complex effects of recombinant tumour necrosis factor a in human ovarian cancer xenograft models. In: M. Melli and L. Parente (eds.). Cytokines and Lipo-cortins in Inflammation and Differentiation, pp. 393-403. New York: Wiley-Liss, Inc. 1990.
26. Malik, S. T. A. Griffin, D. B. Fiers, W. and Balkwill, F. R. Paradoxical effects of tumour necrosis factor in experimental ovarian cancer. Int. J. Cancer, 44: 918-925, 1989.
27. Barsky, S. H. and Gopalakrishna, R. Increased invasion and spontaneous metastasis of BL6 melanoma with inhibition of the desmoplastic response in C57 BL/6 mice. Cancer Res. 47: 1663-1667, 1987.
28. Hewitt, R. E. Powe, D. G. Carter, G. I. and Turner, D. R. Desmoplasia and its relevance to colorectal tumour invasion. Int. J. Cancer, in press, 1992.